Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) Patients

NCT00146770 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis I
Hurler's Syndrome
Hurler-Scheie Syndrome
Scheie Syndrome

Interventions

BIOLOGICAL: Aldurazyme
BIOLOGICAL: Aldurazyme
BIOLOGICAL: placebo

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]